Logo image of TRUG

TRUGOLF HOLDINGS INC-CL A (TRUG) Stock Fundamental Analysis

USA - NASDAQ:TRUG - US2437334095 - Common Stock

2.35 USD
-0.08 (-3.29%)
Last: 10/6/2025, 9:07:02 PM
2.3895 USD
+0.04 (+1.68%)
After Hours: 10/6/2025, 9:07:02 PM
Fundamental Rating

2

Overall TRUG gets a fundamental rating of 2 out of 10. We evaluated TRUG against 80 industry peers in the Entertainment industry. Both the profitability and financial health of TRUG have multiple concerns. TRUG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year TRUG has reported negative net income.
In the past year TRUG has reported a negative cash flow from operations.
TRUG Yearly Net Income VS EBIT VS OCF VS FCFTRUG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of TRUG (-48.92%) is worse than 91.25% of its industry peers.
The Return On Equity of TRUG (-276.24%) is worse than 81.25% of its industry peers.
Industry RankSector Rank
ROA -48.92%
ROE -276.24%
ROIC N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRUG Yearly ROA, ROE, ROICTRUG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 400 600

1.3 Margins

TRUG has a better Gross Margin (61.83%) than 68.75% of its industry peers.
TRUG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRUG Yearly Profit, Operating, Gross MarginsTRUG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

TRUG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TRUG has been reduced compared to 1 year ago.
Compared to 1 year ago, TRUG has a worse debt to assets ratio.
TRUG Yearly Shares OutstandingTRUG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
TRUG Yearly Total Debt VS Total AssetsTRUG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

TRUG has an Altman-Z score of -0.88. This is a bad value and indicates that TRUG is not financially healthy and even has some risk of bankruptcy.
TRUG has a worse Altman-Z score (-0.88) than 76.25% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that TRUG is not too dependend on debt financing.
TRUG's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. TRUG outperforms 53.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -0.88
ROIC/WACCN/A
WACC12.33%
TRUG Yearly LT Debt VS Equity VS FCFTRUG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

TRUG has a Current Ratio of 1.16. This is a normal value and indicates that TRUG is financially healthy and should not expect problems in meeting its short term obligations.
TRUG has a Current ratio (1.16) which is comparable to the rest of the industry.
TRUG has a Quick Ratio of 1.01. This is a normal value and indicates that TRUG is financially healthy and should not expect problems in meeting its short term obligations.
TRUG has a Quick ratio of 1.01. This is comparable to the rest of the industry: TRUG outperforms 47.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.01
TRUG Yearly Current Assets VS Current LiabilitesTRUG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

TRUG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.28%.
TRUG shows a strong growth in Revenue. In the last year, the Revenue has grown by 155.19%.
EPS 1Y (TTM)-113.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.51%
Revenue 1Y (TTM)155.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.3%

3.2 Future

Based on estimates for the next years, TRUG will show a very strong growth in Earnings Per Share. The EPS will grow by 27.07% on average per year.
TRUG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.86% yearly.
EPS Next Y44%
EPS Next 2Y40.13%
EPS Next 3Y27.07%
EPS Next 5YN/A
Revenue Next Year0.38%
Revenue Next 2Y6.14%
Revenue Next 3Y15.86%
Revenue Next 5YN/A

3.3 Evolution

TRUG Yearly Revenue VS EstimatesTRUG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 10M 20M 30M
TRUG Yearly EPS VS EstimatesTRUG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -5 -10

1

4. Valuation

4.1 Price/Earnings Ratio

TRUG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TRUG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRUG Price Earnings VS Forward Price EarningsTRUG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRUG Per share dataTRUG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

TRUG's earnings are expected to grow with 27.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.13%
EPS Next 3Y27.07%

0

5. Dividend

5.1 Amount

No dividends for TRUG!.
Industry RankSector Rank
Dividend Yield N/A

TRUGOLF HOLDINGS INC-CL A

NASDAQ:TRUG (10/6/2025, 9:07:02 PM)

After market: 2.3895 +0.04 (+1.68%)

2.35

-0.08 (-3.29%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-19 2025-08-19/dmh
Earnings (Next)N/A N/A
Inst Owners0.71%
Inst Owner Change0%
Ins Owners15.29%
Ins Owner Change109.09%
Market Cap2.63M
Analysts85
Price Target15.3 (551.06%)
Short Float %9.99%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-83.63%
Min EPS beat(2)-120.59%
Max EPS beat(2)-46.66%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.59%
Min Revenue beat(2)-9.98%
Max Revenue beat(2)-1.2%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-53.12%
PT rev (3m)700%
EPS NQ rev (1m)13.9%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-152%
EPS NY rev (3m)-9350%
Revenue NQ rev (1m)-12.22%
Revenue NQ rev (3m)-16.67%
Revenue NY rev (1m)-3.87%
Revenue NY rev (3m)-9.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)-28.09
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-8.83
FCFYN/A
OCF(TTM)-7.11
OCFYN/A
SpS20.24
BVpS3.85
TBVpS1.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.92%
ROE -276.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.83%
FCFM N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 215.12%
Cap/Sales 8.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.01
Altman-Z -0.88
F-Score4
WACC12.33%
ROIC/WACCN/A
Cap/Depr(3y)108.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.51%
EPS Next Y44%
EPS Next 2Y40.13%
EPS Next 3Y27.07%
EPS Next 5YN/A
Revenue 1Y (TTM)155.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.3%
Revenue Next Year0.38%
Revenue Next 2Y6.14%
Revenue Next 3Y15.86%
Revenue Next 5YN/A
EBIT growth 1Y-38.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-517.85%
EBIT Next 3Y106.96%
EBIT Next 5YN/A
FCF growth 1Y-1683.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1337.42%
OCF growth 3YN/A
OCF growth 5YN/A